Our vision: "Cancer treatment in one dose."
OncoSynergy is a patient-focused biotechnology startup spun out from UCSF and the JLABS South San Francisco incubator. Based in bustling Stamford, Connecticut (~40 mins from NYC), we are creating a new class of cancer medicines to maximize patient survival and quality of life with minimal side effects. We are a small, nimble startup team that launched our first clinical trial in 2020 for glioblastoma (aggressive brain cancer).
While we are at the forefront of potential game changing research, please support our patients. They need you to spread awareness far and wide so that more research is being dedicated to devastating cancers like glioblastoma.
Company Details
- Employees
- 5
- Founded
- 2011
- Address
- Stamford, Connecticut 06902, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oncosynergy.com/
- Keywords
- Los Angeles.
- HQ
- Stamford, Connecticut
Oncosynergy Questions
Oncosynergy's website is http://www.oncosynergy.com/
Oncosynergy's LinkedIn profile is https://www.linkedin.com/company/oncosynergy
Oncosynergy has
5 employees.
View email and phone details for 5
employees at Oncosynergy.
Oncosynergy's industry is
Biotechnology Research
Oncosynergy's top competitors are
Nlabs Inc.,
Veea Inc.,
Guardian Bio,
Brazen Capital,
Brazen Bio,
Veina,
The Stroke Foundation,
Enrich Biosystems Inc.,
Biogenesis,
Cure Glioblastoma.
Oncosynergy's categories are Biotechnology Research
Oncosynergy's founding year is 2011
